BARDA Releases Five-Year Plan to Combat CBRN Threats

The U.S. Biomedical Advanced Research Development Authority (BARDA) has released a five-year strategic plan that, among other forecasts, anticipates there will be a number of new projects to combat biological and chemical threats ready for regulatory review in the next few years. BARDA has presently a robust development pipeline of more than 70 medical countermeasures for chemical, biological, radiological and nuclear threats, according to Robin Robinson, PhD, Director for the Biomedical Adv...
To continue reading this story get free access